Diabetes 54:2080-2089, 2005
© 2005 by the American Diabetes Association, Inc.
Role for ß1 Integrin and Its Associated 3, 5, and 6 Subunits in Development of the Human Fetal Pancreas
Rennian Wang1,2,
Jinming Li1,
Kristina Lyte1,
Nina K. Yashpal1,
Fraser Fellows3, and
Cynthia G. Goodyer4
1 Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada
2 Department of Medicine, University of Western Ontario, London, Ontario, Canada
3 Department of Obstetrics and Gynecology, University of Western Ontario, London, Ontario, Canada
4 Department of Pediatrics, McGill University, Montreal, Quebec, Canada
The integrin receptors play a major role in tissue morphogenesis and homeostasis by regulating cell interactions with extracellular matrix proteins. We have examined the expression pattern of integrin subunits in the human fetal pancreas (8–20 weeks fetal age) and the relevance of ß1 integrin function for insulin gene expression and islet cell survival. Its subunits 3, 5, and 6 ß1 integrins are expressed in ductal cells at 8 weeks, before glucagon- and insulin-immunoreactive cells bud off; their levels gradually increase in both ductal cells and islet clusters up to 20 weeks. Colocalization of 3, 5 and 6 ß1 integrins with endocrine cell markers was frequently observed in 8- to 20-week fetal pancreatic cells. When the ß1 integrin receptor was functionally blocked in cultured islet-epithelial clusters with a ß1 immunoneutralizing antibody or following transient ß1 integrin small interfering RNA treatment, there was inhibition of cell adhesion to extracellular matrices, decreased expression of insulin, and increased cell apoptosis. These data offer evidence for dynamic and cell-specific changes in integrin expression during human pancreatic islet neogenesis. They also provide an initial insight into a molecular basis for cell-matrix interactions during islet development and suggest that ß1 integrin plays a vital role in regulating islet cell adhesion, gene expression, and survival.
Address correspondence and reprint requests to Dr. Rennian Wang, Victoria Laboratory Centre, Room A5-140, 800 Commissioners Rd. E, London, Ontario, N6C 2V5, Canada. E-mail: rwang{at}uwo.ca
Abbreviations:
ECM, extracellular matrix; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; siRNA, small interfering RNA; TRITC, tetramethylrhodamine isothiocyanate; TUNEL, transferase-mediated dUTP nick-end labeling

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Brands, E. Colvin, L. J. Williams, R. Wang, R. B. Lock, and B. E. Tuch
Reduced Immunogenicity of First-Trimester Human Fetal Pancreas
Diabetes,
March 1, 2008;
57(3):
627 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, J. Quirt, H. Q. Do, K. Lyte, F. Fellows, C. G. Goodyer, and R. Wang
Expression of c-Kit receptor tyrosine kinase and effect on beta-cell development in the human fetal pancreas
Am J Physiol Endocrinol Metab,
August 1, 2007;
293(2):
E475 - E483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Parnaud, E. Hammar, D. G. Rouiller, M. Armanet, P. A. Halban, and D. Bosco
Blockade of {beta}1 Integrin-Laminin-5 Interaction Affects Spreading and Insulin Secretion of Rat {beta}-Cells Attached on Extracellular Matrix.
Diabetes,
May 1, 2006;
55(5):
1413 - 1420.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|